GlassScriptPhysician profile
Christopher Gadsden Carsten
NPI 1275586471
$8,491.80
in general payments reported to CMS, 2019-2025
32 companies · $1,938 in 2025
The $1,938 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $498 · 2021: $402 · 2022: $817 · 2023: $1,502 · 2024: $2,395 · 2025: $1,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,835.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,224.08 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Gore Tag Thoracic Branch Endoprosthesis |
| Cook Medical LLC | $1,671.40 | 2020-2025 | Zilver Ptx, Rosen, Tornado |
| Inari Medical, INC. | $1,594.61 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $493.38 | 2020-2025 | Indigo System, Penumbra System |
| Shockwave Medical, INC | $427.38 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $350.40 | 2024-2025 | Endurant Iis, Fortrex, Evercross |
| Stryker Corporation | $233.54 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $221.84 | 2022 | |
| Bard Peripheral Vascular, INC. | $154.49 | 2019-2022 | |
| Reddress USA, INC. | $143.62 | 2025 | Actigraft |
| Boston Scientific Corporation | $134.49 | 2020-2025 | Eluvia, General - Therapies |
| Teleflex LLC | $124.77 | 2024 | Manta |
| Endologix LLC | $87.01 | 2021 | |
| Bioventus LLC | $81.74 | 2022 | |
| Terumo Medical Corporation | $67.43 | 2024-2025 | Azur Cx Detachable, Navicross |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Venturemed Group, INC. | $61.04 | 2025 | Flex Vessel Prep System |
| Philips North America LLC | $51.12 | 2019-2024 | (Br5) Peripheral Ivus |
| Urgo Medical North America, LLC | $46.11 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Surmodics, INC. | $43.35 | 2024 | Pounce Venous Thrombectomy System |
| Angiodynamics, INC. | $41.42 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Shape Memory Medical INC. | $40.00 | 2025 | Impede Embolization Plug |
| Imperative Care, INC | $34.92 | 2025 | Symphony Catheter |
| Inspiremd LTD | $32.70 | 2025 | Cguard Prime Carotid Stent System |
| Ethicon US, LLC | $19.42 | 2021 | |
| Abbott Laboratories | $17.84 | 2024 | Armada |
| Sirtex Medical INC | $17.28 | 2024 | Lava Les (Liquid Embolic System) |
| Reprise Biomedical, INC. | $17.05 | 2025 | Miro3d |
| Smith+Nephew, INC. | $15.92 | 2025 | Collagenase Santyl |
| Acera Surgical, INC. | $15.20 | 2025 | Restrata Wound Matrix |
| Teva Pharmaceuticals USA, INC. | $14.49 | 2020 | |
| Cagent Vascular INC | $13.76 | 2025 | Serrantor |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carsten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.